27th Dubai International Pharmaceutical & Technologies Conference & Exhibition - DUPHAT
Committed to providing complete solutions in pharmaceuticals
DUPHAT 2022 Exhibition
Annual gathering of the top global pharmaceuticals & manufacturing suppliers
DUPHAT 2022 Conference
A 3 day must attend conference by international and regional experts
Pharma Business Hub
An exclusive meeting place for exhibitors and handpicked Industry Executives
MENA’s largest gathering of the entire pharmaceutical value chain – from suppliers, manufacturers, distributors to pharmacists.
DUPHAT is committed to providing a complete solution to the pharmaceutical industry. This unique event brings the entire value chain of the pharma industry from the suppliers of raw material to the manufacturers of formulation, to the distributors and pharmacy networks.
- Build relations and network with 20,000+ Attendees
- Pre-book B2B meetings with 60+ handpicked Buyers
- Generate new leads from 75+ Participating Countries
Be part of the largest pharma business networking event attracting buyers & Suppliers from across the MEA region
Viatris is set with a mission to provide to patients to live a healthier life through every stage of their lives through 3 pillars: access, partnerships and leadership. We are honored to be in DUPHAT, as it is one of the biggest pharma conferences in the region and a very good opportunity for us to connect with healthcare professionals. This year we are seeing lots of transformations in the pharma industry, and DUPHAT is setting an example by taking all the precautionary and safety measures to make sure we feel safe. So I encourage everyone to visit DUPHAT and UAE as you will feel safe and live in the new norm.
Tamar El Salleb
Head of Gulf & Levant Cluster Viatris, Dubai
We have brought a range of our capabilities in terms of distribution, in house brands, marketing and promotion across UAE, to DUPHAT. Al Khayyat has been a presenter with great engagement as a part of their distribution strategy to make sure we can offer our strongest capabilities. DUPHAT, for AKI, is the perfect platform to identify and develop new partnerships and business opportunities. The social distancing measures, mask requirements and sanitization options have been well implemented and we feel very safe in this environment. We have also had a number of successful meetings with companies from several European markets who have come over to DUPHAT to seek competitive distributors.
Head of Marketing pharma/Healthcare, AKI Healthcare,DUBAI
This event brings all the pharmaceutical industries together in one platform and is a good launch for companies like Magenta, that invest in unique opportunities. This is the right forum where we connect with the rest of the industry. The organizers were also very diligent and made sure everything was up to the standard. The limited stand capacity facilitates all our presence and we are happy to be in the event. Thank you to the organizers for the well-organized event.
Head, Regular, Quality & Pharmacovigilance in Magenta pharma, Dubai
Our Scientific Activities
Bringing the pharma industry together
A learning ground to help you develop your practice.
Continuously nurturing the next generation
Expert Speaker lineup
Over the course of three days, the DUPHAT conference brings the world’s most renowned, scientific speakers and inspirational business leaders.
Professor and Dean Emeritus Faculty of Pharmaceutical Sciences | Canada
Professor and Dean Emeritus Faculty of Pharmaceutical Sciences
Dr. Sindelar is a Professor and Dean Emeritus, Faculty of Pharmaceutical Sciences, University of British Columbia (UBC). Dr. Sindelar is also an elected fellow of the Canadian Academy of Health Sciences, and an elected fellow of the International Pharmaceutical Federation (FIP). He is Adjunct Professor of Medicinal Chemistry and Adjunct Research Professor of the Research Institute of Pharmaceutical Sciences, The School of Pharmacy, The University of Mississippi. Currently, he serves as the Chair of the FIP “Global Pharmacy Observatory Data & Intelligence Presidential Commission, to provide strategic advice on the development of the Global Pharmaceutical Observatory working with FIP stakeholders including WHO. He is also the Head of Pharmaceutical Sciences, the Athens Institute for Education and Research. Professor Sindelar previously served as Vice President of Innovation, Research & Academic Affairs at Providence Health Care (PHC), President of the PHC Research Institute and Associate Dean Research in the UBC Faculty of Medicine (2013-2016). He is a founder of the Centre for Drug Research and Development (formerly CDRD, now called adMare BioInnovations), a national not-for-profit drug development and commercialization centre. Also, he has served as President of the Global Drug Commercialization Centre (GDCC)-China, and Vice President, GDCC-Worldwide (2017-2019), a translational medicine endeavor that facilitates the innovative development of healthcare initiatives. In these various roles, he continues to contribute to health science research, health policy development, team-building, international partnerships, as well as strategic innovations. Dr. Sindelar completed a M.S. degree and a Ph.D. in Medicinal Chemistry and Natural Products at the University of Iowa School of Pharmacy. His research expertise is in medicinal chemistry, computer-aided drug discovery, and pharmaceutical biotechnology. He is the recipient of several School and University-wide teaching honors and has co-edited 5 editions of the highly successful textbook entitled “Pharmaceutical Biotechnology: Fundamentals and Applications.”
Lectures by this speaker
The Pharmacist and RNA-Based Medicines
11:00 - 12:00
Co-Founder & Chief Executive Officer of Afaq Alwataniyah Company and the Managing Director/Senior Consultant | Saudi Arabia
Co-Founder & Chief Executive Officer of Afaq Alwataniyah Company and the Managing Director/Senior Consultant
Dr. Al-Khars has a Master in Applied Business Research from Swiss Business School, Switzerland; a Master in Business Administration specialized in International Business from the University of Florida, USA and a special diploma degree in new venture creation from the same university. He received a Bachelor degree in Pharmaceutical Science from King Saud University, Riyadh, Saudi Arabia with honor and Master Degree in Clinical Pharmacy from the same university. His academic history includes a Specialty Residency in Pharmacy Practice Management at Detroit Receiving Hospital and Wayne State University, Detroit, Michigan, USA. His research interests include health care quality improvement, health care reform, the economic evaluation of treatment strategies, health care educational system and technologies, and pharmacy practice management. In addition to his teaching and management activities, Dr. Al-Khars has conducted many presentations, executive seminars and management development programs in different countries including Saudi Arabia, USA, Germany, Malaysia, Lebanon, Oman, Egypt, and United Arab Emirates.
Lectures by this speaker
Bridging Gaps and Removing Barriers: Applying 7s Mckinsey Model within Pharmacy Sectors
13:00 - 14:00
Barry A. Bleidt
Professor, Sociobehavioral and Administrative Sciences, College of Pharmacy | USA
Barry A. Bleidt
Professor, Sociobehavioral and Administrative Sciences, College of Pharmacy
Dr. Bleidt is a Professor of Sociobehavioral and Administrative Pharmacy at Nova Southeastern University. He received his BS Pharmacy from the University of Kentucky, PhD in Pharmacy Healthcare Administration from the University of Florida, and his PharmD from Xavier University of Louisiana. Barry has forty years of professional experience in preventing drug use problems and substance misuse. Dr. Bleidt served fourteen years as Chair of the Program Committee for the Alcohol, Tobacco, and Other Drugs Section of the American Public Health Association and five years for the Pharmacy Section, twenty-three years as the parliamentarian of the American Association of Colleges of Pharmacy, and twenty-one years as the Director of Continuing Pharmacy Education for the National Pharmaceutical Association. He has served as a Delegate to the United States Pharmacopoeia Convention since 1985. Dr. Bleidt has delivered over 400 presentations and published nearly fifty works. Some of his publications include the books: Clinical Research in Pharmaceutical Development, Multicultural Pharmaceutical Education, and A Guide to the Top 200 Drugs. Dr. Bleidt was inducted as a Fellow into the APhA Academy of Pharmaceutical Research and Science in 2015. He received the 2013 Chauncey I Cooper Award (the highest honor bestowed by NPhA), 2007 Award for Innovative and Exemplary Contributions to the NPhA Foundation, the Ilene B. Stiff Local Association President’s Award as the leader of the Virginia Pharmacists Association Local Association of the Year (2001), the James M. Tyson Award (2nd Highest Honor from NPhA (2001);and the American Public Health Association Leadership Award from the Alcohol, Tobacco, and Other Drugs Section (2000). He currently resides in Ft. Lauderdale, Florida.
Lectures by this speaker
Pharmacy for Future – The Advance and Impacts
10:00 - 10:45
Chronic Disease State Management
13:00 - 13:45
Professor, Pharmaceutics Former Vice President for Research, Pharco Corporation Former Chairman, National Organization for Drug Control And Research | Egypt
Professor, Pharmaceutics Former Vice President for Research, Pharco Corporation Former Chairman, National Organization for Drug Control And Research
Prof. Molokhia obtained his PhD from the University of Michigan, USA 1973. He held academic positions at Universities of Houston, Riyadh and Alexandria and is a current member of the Egyptian National Pharmacology Committee. He advised more than 52 PhD and MS candidates and co-authored more than 158 original manuscripts and presentations to national and international conferences. Between 1996-2004, he was the chairman of the Egyptian National Organization for Drug Control and Research at the Ministry of Health. From 2004 until 2013, he chaired the European Egyptian Pharmaceutical Industries Company, a division of Pharco Pharmaceuticals, Alexandria, Egypt. Between 2007-2013, he chaired the Pharmaceutical Sector of the Pharmaceuticals and Cosmetic Chamber at the Egyptian Industry Union. Prof. Molokhia chaired several conferences organized among NODCAR, the MOH and the WHO. As consultant to the WHO, he presented training and consultations to nine countries in the EMRO region. Prof. Molokhia co-chaired 5 Egyptian-USP Symposia on “Science and Standards”. He acts as observer representing the Egyptian Chamber of Pharmaceuticals with the USP Convention.
Lectures by this speaker
Drug Supply Chain Threats and Pandemic Impact
11:45 - 12:30
Opportunities in Pharmacoeconomics for Pharmacists at Different Practice Sites
10:00 - 11:00
Vice President, Global Resource Development and Consulting, ASHP | USA
Vice President, Global Resource Development and Consulting, ASHP
Vice President, Global Resource Development and Consulting, ASHP Clinical Professor (Adjunct) University of North Carolina Eshelman School of Pharmacy Professor of Pharmacy Practice Campbell University College of Pharmacy and Health Sciences
Overlaying Retinitis Pigmentosa (RP) Management in the MENA Region
November 22, 2021
An analysis of the current scenario and future perspective of Retinitis Pigmentosa epidemiology and management specific to the MENA region! Retinitis Pigmentosa is inherited retinal dystrophy caused by the gradual atrophy of the photoreceptor cells in the retina and characterized by progressive degeneration of the retina and progressive vision loss […]
Cancer diagnosis in the MENA region: Headway toward a better future
November 18, 2021
Cancer is an increasing problem not just in the Middle East and North Africa (MENA) region but also globally, securing a significant place as the leading cause of death. It is a major public health problem that affects every country in the MENA region regardless of economic and social situation. […]
H.H. Sheikh Ahmed Bin Saeed Al Maktoum Officially Inaugurates the 26th Edition of DUPHAT
August 15, 2021
His Highness Sheikh Ahmed Bin Saeed Al Maktoum, President of Dubai Civil Aviation Authority, Chairman & CEO of Emirates Group and Chairman of Dubai Airports officially inaugurated today the 26th edition of Dubai International Pharmaceuticals & Technologies Conference and Exhibition – DUPHAT, the biggest pharmaceutical event in the Middle East […]
DUPHAT Commences on its Second Day
August 15, 2021
The 26th edition of the Dubai International Pharmaceuticals & Technologies Conference & Exhibition ‘DUPHAT’, the biggest pharmaceutical event in the Middle East North Africa region commenced on the 2nd day at the Dubai World Trade Center. This specialized event runs until the 7th of April, 2021 and has attracted a […]
The Corona pandemic has taken center stage and tops the list of healthcare priorities worldwide
August 15, 2021
The 26th edition of Dubai International Pharmaceuticals and Technologies Conference and Exhibition – DUPHAT successfully concluded today at the Dubai World Trade Center. The 3-day premier pharma event featured a number of key scientific sessions, workshops and highly specialized sessions which focused on presenting the most up-to-date knowledge and advances […]
Partners & Sponsors
Special thanks to the support, involvement and active contribution of our Sponsors and Partners.